Wanqing Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wanqing Sun has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Fengsheng Li
People's Liberation Army (PLA) of China Rocket Force Characteristic Medical Center, Beijing, China
1 shared publication - Ki Soo Kim
The Bioland Biotec Co., Ltd., Zhangjiang Modern Medical Device Park, Pudong, Shanghai 201203, China
1 shared publication - Kyoung Tae Kim
The Bioland Biotec Co., Ltd., Zhangjiang Modern Medical Device Park, Pudong, Shanghai 201203, China
1 shared publication - Ling Gao
National Institute for Radiological Protection, China Centers for Disease Control
1 shared publication - Lu Cai
Pediatric Research Institute, Department of Pediatrics, University of Louisville, Louisville, KY 40202, USA
1 shared publication Meihua Sun
Department of Pediatrics, the First Hospital of Jilin University, Changchun, 130021, China
1 shared publication
Latest Publications
- 1 March 2021
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 165, 385-394
Sestrin2 is an endogenous antioxidant that improves contractile function in the heart during exposure to ischemia and reperfusion stress
- 1 March 2021
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 165, 385-394
Sestrin2 is an endogenous antioxidant that improves contractile function in the heart during exposure to ischemia and reperfusion stress
- Open Access
- 24 September 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (10) , 1629
Extracts of Magnolia Species-Induced Prevention of Diabetic Complications: A Brief Review
Diabetic complications are the major cause of mortality for the patients with diabetes. Oxidative stress and inflammation have been recognized as important contributors for the development of many diabetic complications, such as diabetic nephropathy, hepatopathy, cardiomyopathy, and other cardiovascular diseases. Several studies have established the anti-inflammatory and oxidative roles of bioactive constituents in Magnolia bark, which has been widely used in the traditional herbal medicines in Chinese society. These findings have attracted various scientists to investigate the effect of bioactive constituents in Magnolia bark on diabetic complications. The aim of this review is to present a systematic overview of bioactive constituents in Magnolia bark that induce the prevention of obesity, hyperglycemia, hyperlipidemia, and diabetic complications, including cardiovascular, liver, and kidney.
- 24 September 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (10) , 1629
Open AccessExtracts of Magnolia Species-Induced Prevention of Diabetic Complications: A Brief Review
Diabetic complications are the major cause of mortality for the patients with diabetes. Oxidative stress and inflammation have been recognized as important contributors for the development of many diabetic complications, such as diabetic nephropathy, hepatopathy, cardiomyopathy, and other cardiovascular diseases. Several studies have established the anti-inflammatory and oxidative roles of bioactive constituents in Magnolia bark, which has been widely used in the traditional herbal medicines in Chinese society. These findings have attracted various scientists to investigate the effect of bioactive constituents in Magnolia bark on diabetic complications. The aim of this review is to present a systematic overview of bioactive constituents in Magnolia bark that induce the prevention of obesity, hyperglycemia, hyperlipidemia, and diabetic complications, including cardiovascular, liver, and kidney.